Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?

Saved in:
Bibliographic Details
Published in:Cardiovascular drugs and therapy 2018-06, Vol.32 (3), p.311-311
Main Authors: Jonnalagadda, Venu Gopal, Char, Harish Prabhanna, Ankana, Praveen Kumar
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular Diseases
Cholesterol, LDL
Diabetes mellitus
Diabetes Mellitus, Type 2
Dyslipidemia
Dyslipidemias
Health risks
Humans
Letter to the Editor
Medicine
Medicine & Public Health
Metabolic disorders
Pyrimidines
Risk Factors
Sitagliptin Phosphate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0920-3206
1573-7241
DOI:10.1007/s10557-018-6779-9